第 1 到 54 筆結果,共 54 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2024 | A case of primary pleural epithelioid hemangioendothelioma achieving stable disease with paclitaxel treatment: A case report and literature review | Chou, Chun-Ying; Hu, Hsiang-Wei; WEI-WU CHEN ; SHU-YUNG LIN | Respirology case reports | |||
2 | 2024 | Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial | WEI-WU CHEN ; Dai, Ming-Shen; Tseng, Ling-Ming; Chen, Shin-Cheh; Chao, Tsu-Yi; Chao, Ta-Chung; Chang, Yuan-Ching; Chiu, Chang-Fang; Liu, Chien-Ting; Lin, Ching-Hung; Liu, Chun-Yu; YA-FANG CHEN ; DWANG-YING CHANG ; Yu, Jyh-Cherng; Rau, Kun-Ming; Hsieh, Yao-Yu; Shen, Shih-Che; Huang, Shu-Min; ANN-LII CHENG ; YEN-SHEN LU | JAMA oncology | 1 | ||
3 | 2023 | Delay of Surgery for Spinal Metastasis due to the COVID-19 Outbreak Affected Patient Outcomes | Hsieh, Chia-Jung; CHUN-YU WU ; YEN-HENG LIN ; Huang, Yu-Cheng; Yang, Wen-Chi; WEI-WU CHEN ; WEI-LI MA ; WEI-HSIN LIN ; FENG-MING HSU; FU-REN XIAO ; SHIH-HUNG YANG ; DAR-MING LAI ; CHANG-MU CHEN ; Chao, Shin-Yi; FON-YIH TSUANG | Neurospine | 0 | ||
4 | 2023 | Disparity in survival benefits of pembrolizumab between Asian and non-Asian patients with advanced cancers: A systematic review and meta-regression analysis | Peng, Shang-Hsuan; CHING-HUNG LIN ; I-CHUN CHEN ; YING-CHUN SHEN ; DWANG-YING CHANG ; WEI-WU CHEN ; Huang, Shu-Min; Hu, Fu-Chang; YEN-SHEN LU | Cancer medicine | 0 | 0 | |
5 | 2023 | The Application of18F-FES PET in Clinical Cancer Care: A Systematic Review | Huang, Ya-Ting; WEI-WU CHEN ; Chen, Li-Yu; Huang, Ya-Yao; YEN-SHEN LU | Clinical nuclear medicine | 1 | 0 | |
6 | 2023 | New targeted treatments for advanced sarcomas | CHIA-CHEN LI ; WEI-WU CHEN | Current opinion in oncology | 1 | 0 | |
7 | 2023 | The proteomic landscape of soft tissue sarcomas | Burns, Jessica; Wilding, Christopher P; Krasny, Lukas; Zhu, Xixuan; Chadha, Madhumeeta; Tam, Yuen Bun; Ps, Hari; Mahalingam, Aswanth H; Lee, Alexander T J; Arthur, Amani; Guljar, Nafia; Perkins, Emma; Pankova, Valeriya; Jenks, Andrew; Djabatey, Vanessa; Szecsei, Cornelia; McCarthy, Frank; Ragulan, Chanthirika; Milighetti, Martina; Roumeliotis, Theodoros I; Crosier, Stephen; Finetti, Martina; Choudhary, Jyoti S; Judson, Ian; Fisher, Cyril; Schuster, Eugene F; Sadanandam, Anguraj; WEI-WU CHEN ; Williamson, Daniel; Thway, Khin; Jones, Robin L; Cheang, Maggie C U; Huang, Paul H | Nature communications | 7 | 1 | |
8 | 2023 | Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer | WEI-WU CHEN ; Hsiao, Wen; Dai, Ming-Shen; CHING-HUNG LIN ; DWANG-YING CHANG ; I-CHUN CHEN ; MING-YANG WANG ; Chang, Shu-Han; Huang, Shu-Min; ANN-LII CHENG ; Wu, Ko-Wen; Tan, Kien Thiam; YEN-SHEN LU | Breast cancer research and treatment | 0 | 0 | |
9 | 2023 | Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma | HUANG-CHUN LIEN ; Hsu, Chia-Lang; YEN-SHEN LU ; WEI-WU CHEN ; I-CHUN CHEN ; Li, Yu-Chia; CHIUN-SHENG HUANG ; ANN-LII CHENG ; CHING-HUNG LIN | Breast cancer research : BCR | 2 | 0 | |
10 | 2022 | A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma | WEI-WU CHEN ; CHIA-LANG HSU ; RUEY-LONG HONG ; JEN-CHIEH LEE ; Chang, Koping; CHIH-WEI YU ; Chen, San-Chi; JHE-CYUAN GUO ; Chen, Mei-Lu; Hsu, Meng-Chi; Kung, Ting-Fang; ANN-LII CHENG ; Yen, Chueh-Chuan | Clinical cancer research : an official journal of the American Association for Cancer Research | 6 | 6 | |
11 | 2022 | XPF activates break-induced telomere synthesis | Guh, Chia-Yu; Shen, Hong-Jhih; Chen, Liv WeiChien; Chiu, Pei-Chen; Liao, I-Hsin; Lo, Chen-Chia; Chen, Yunfei; Hsieh, Yu-Hung; Chang, Ting-Chia; Yen, Chien-Ping; Chen, Yi-Yun; WEI-WU CHEN ; Chen, Liuh-Yow; Wu, Ching-Shyi; Egly, Jean-Marc; HSUEH-PING CHU | Nature communications | 8 | 7 | |
12 | 2022 | Soft tissue sarcoma incidences and clinical characteristics are significantly different in France and Taiwan | WEI-WU CHEN ; Chiang, Ruru Chun-Ju; Le Cesne, Alex; Hsieh, Yu-Chun; Italiano, Antoine; Yang, Ya-Wen; Penel, Nicolas; WEN-CHUNG LEE ; Bompas, Emmanuelle; Valentin, Thibaud; Anract, Philippe; Firmin, Nelly; Duffaud, Florence; ANN-LII CHENG ; Ducimetiere, Francoise; KIN-WEI CHAN ; Blay, Jean-Yves | Cancer | 3 | 2 | |
13 | 2022 | Malignant granular cell tumour at the interventricular septum | Lou, Weng-Kin; HENG-WEN CHOU ; WEI-WU CHEN ; CHE-YU HSU ; JENG-WEI CHEN | Interactive cardiovascular and thoracic surgery | 0 | 0 | |
14 | 2022 | Revisiting Adjuvant Hormone Therapy in Premenopausal Women With Breast Cancer: Escalation and De-Escalation | Chen, Hsing-Wu; WEI-WU CHEN | JCO oncology practice | 0 | 0 | |
15 | 2022 | Tumor Immune Microenvironment of Soft Tissue Sarcoma | WEI-WU CHEN ; SHENG-FANG SU ; Tseng, William W. | Cancer Metastasis Through the Lymphovascular System | 1 | 0 | |
16 | 2022 | Brain Tumor Segmentation (BraTS) Challenge Short Paper: Improving Three-Dimensional Brain Tumor Segmentation Using SegResnet and Hybrid Boundary-Dice Loss | CHE-YU HSU ; Chang, Chunhao; WEI-WU CHEN ; Tsai, Hsinhan; Ma, Shihchieh; WEICHUNG WANG | Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) | 3 | 0 | |
17 | 2022 | Spectrum of cancer patients receiving renal biopsy | FAN-CHI CHANG ; WEI-WU CHEN ; TAO-MIN HUANG ; WEI-CHOU LIN ; Liu, Jia-Sin; WEN-CHIH CHIANG ; YUNG-MING CHEN ; CHIUN HSU ; KUN-HUEI YEH ; TZONG-SHINN CHU | Journal of the Formosan Medical Association = Taiwan yi zhi | 1 | 0 | |
18 | 2021 | The treatment landscape of advanced angiosarcoma in Asia-A multi-national collaboration from the Asian Sarcoma Consortium | WEI-WU CHEN ; Pang A.; Puhaindran M.E.; Maw M.M.; Loong H.H.; Sriuranpong V.; Chang C.-C.; Mingmalairak S.; Hirose T.; Endo M.; Kawai A.; Farid M.; Tan S.H.; Goh W.L.; Quek R.; Chan J.C.H.; Leung A.K.C.; Ngan R.K.C. | Cancer Science | 9 | ||
19 | 2021 | Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature | Frezza A.M.; Ravi V.; Lo Vullo S.; Vincenzi B.; Tolomeo F.; WEI-WU CHEN ; Teterycz P.; Baldi G.G.; Italiano A.; Penel N.; Brunello A.; Duffaud F.; Hindi N.; Iwata S.; Smrke A.; Fedenko A.; Gelderblom H.; Van Der Graaf W.; Vozy A.; Connolly E.; Grassi M.; Benjamin R.S.; Broto J.-M.; Grignani G.; Jones R.L.; Kawai A.; Tysarowski A.; Mariani L.; Casali P.G.; Stacchiotti S. | Cancer Medicine | 21 | 18 | |
20 | 2021 | Tumor-infiltrating lymphocyte abundance and programmed death-ligand 1 expression in metaplastic breast carcinoma: implications for distinct immune microenvironments in different metaplastic components | HUANG-CHUN LIEN ; Lee Y.-H.; I-CHUN CHEN ; CHING-HUNG LIN ; WEI-WU CHEN ; Lu Y.-T.; YEN-SHEN LU | Virchows Archiv | 15 | 13 | |
21 | 2021 | B cells and cancer: To B or not to B? | Fridman W.H.; Petitprez F.; Meylan M.; WEI-WU CHEN ; Sun C.-M.; Roumenina L.T.; Saut?s-Fridman C. | Journal of Experimental Medicine | 98 | 76 | |
22 | 2020 | Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survival | WEI-WU CHEN ; I-SHIOW JAN ; DWANG-YING CHANG ; CHING-HUNG LIN ; I-CHUN CHEN ; Chen H.-M.; ANN-LII CHENG ; YEN-SHEN LU | Journal of Neuro-Oncology | 17 | 13 | |
23 | 2020 | A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors | JIH-HSIANG LEE ; WEI-WU CHEN ; CHIH-HUNG HSU ; Yen Y.-H.; CHIH-HSIN YANG ; ANN-LII CHENG ; Sasaki S.-I.; Chiu L.Y.; Sugihara M.; Ishizuka T.; Oguma T.; Tajima N.; CHIA-CHI LIN | Investigational New Drugs | 39 | 36 | |
24 | 2020 | Optimal clinical management and the molecular biology of angiosarcomas | WEI-WU CHEN ; Burns J.; Jones R.L.; Huang P.H. | Cancers | 15 | 16 | |
25 | 2020 | When molecular-targeted agents meet immunotherapy: The opportunities for soft tissue sarcoma | Wainsztein V.E.; WEI-WU CHEN | Journal of Immunotherapy and Precision Oncology | 2 | 0 | |
26 | 2020 | Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study | Gounder M.; Sch?ffski P.; Jones R.L.; Agulnik M.; Cote G.M.; Villalobos V.M.; Attia S.; Chugh R.; WEI-WU CHEN ; Jahan T.; Loggers E.T.; Gupta A.; Italiano A.; Demetri G.D.; Ratan R.; Davis L.E.; Mir O.; Dileo P.; Van Tine B.A.; Pressey J.G.; Lingaraj T.; Rajarethinam A.; Sierra L.; Agarwal S.; Stacchiotti S. | The Lancet Oncology | 202 | 149 | |
27 | 2020 | Genomic-guided precision therapy for soft tissue sarcoma | Chen H.-W.; WEI-WU CHEN | ESMO Open | 6 | 3 | |
28 | 2020 | The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma | Heng M.; Gupta A.; Chung P.W.; Healey J.H.; Vaynrub M.; Rose P.S.; Houdek M.T.; Lin P.P.; Bishop A.J.; Hornicek F.J.; Chen Y.-L.; Lozano-Calderon S.; Holt G.E.; Han I.; Biau D.; Niu X.; Bernthal N.M.; Ferguson P.C.; Wunder J.S.; Ueda T.; Kakunaga S.; Kawai A.; Sugiura H.; Kidani T.; Kunisasa T.; Ozaki T.; Ae K.; Nagano A.; Ohno T.; Hiraoka K.; Yamamoto N.; Tsuchiya H.; Matsumoto Y.; Yanagawa T.; Nakayama R.; Morioka H.; Kubo T.; Simose S.; Yamagami Y.; Yamamoto T.; Kawasaki M.; Torigoe T.; Yazawa Y.; Akiyama T.; Gokita T.; Manabe J.; Kaya M.; Emori M.; Nakamura T.; Matsumine A.; Sugihara S.; Yokouchi M.; Komiya S.; Suehara Y.; Takagi T.; Kawamoto T.; Wasa J.; Yonemoto T.; Ishii T.; Baba I.; Hoshi M.; Hamada K.; Naka N.; Sotobori T.; Araki N.; Okuma T.; Goto T.; Kobayashi H.; Kawano H.; Hosaka M.; Futani H.; Hiraga H.; Nishida Y.; Griffin A.; Razak A.R.A.; Shultz D.B.; Catton C.; Robinson S.; Patel S.R.; Lewis V.O.; Guadagnolo B.A.; DeLaney T.; Wang H.; Raskin K.; Callan A.K.; Henshaw R.; Isler M.; Mottard S.; Chen W.-M.; Traub F.; WEI-WU CHEN ; Turcotte R.E.; Davidson D.; Tunn P.-U.; Loong H.; Ghert M.; Werier J.; Clarkson P.; Abraham J.A.; Japanese Musculoskeletal Oncology Group (JMOG), Soft Tissue Osteosarcoma International Collaborative (STOIC) | European Journal of Cancer | 49 | 42 | |
29 | 2020 | Tertiary Lymphoid Structures and B cells: Clinical impact and therapeutic modulation in cancer | Saut?s-Fridman C.; Verneau J.; Sun C.-M.; Moreira M.; WEI-WU CHEN ; Meylan M.; Petitprez F.; Fridman W.H. | Seminars in Immunology | 47 | 36 | |
30 | 2020 | B cells are associated with survival and immunotherapy response in sarcoma | Petitprez F.; de Reyniès A.; Keung E.Z.; WEI-WU CHEN ; Sun C.-M.; Calderaro J.; YUNG-MING JENG ; Hsiao L.-P.; Lacroix L.; Bougoüin A.; Moreira M.; Lacroix G.; Natario I.; Adam J.; Lucchesi C.; Laizet Y.; Toulmonde M.; Burgess M.A.; Bolejack V.; Reinke D.; Wani K.M.; Wang W.-L.; Lazar A.J.; Roland C.L.; Wargo J.A.; Italiano A.; Sautès-Fridman C.; Tawbi H.A.; Fridman W.H. | Nature | 1051 | 955 | |
31 | 2019 | Primary Ewing Family of Tumor Arising in the Ovary: A Case Report | Li, Yi-Ping; Chang, Koping; WEI-WU CHEN ; Lee, Shu-Ping; CHI-AN CHEN ; WEN-FANG CHENG | International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists | 4 | 2 | |
32 | 2019 | Clinicopathologic Characterization of GREB1 -rearranged Uterine Sarcomas With Variable Sex-Cord Differentiation | Lee C.-H.; Kao Y.-C.; Lee W.-R.; Hsiao Y.-W.; TZU-PIN LU ; Chu C.-Y.; Lin Y.-J.; Huang H.-Y.; Hsieh T.-H.; Liu Y.-R.; Liang C.-W.; WEI-WU CHEN ; Yip S.; Lum A.; KUAN-TING KUO ; YUNG-MING JENG ; Yu S.-C.; Chung Y.-C.; JEN-CHIEH LEE | American Journal of Surgical Pathology | 41 | 33 | |
33 | 2019 | Prognostic factors and treatment outcomes of malignant pleural mesothelioma in Eastern Asian patients – A Taiwanese study | Wu T.-H.; Lee L.J.-H.; CHANG-TSU YUAN ; WEI-WU CHEN ; CHIH-HSIN YANG | Journal of the Formosan Medical Association | 7 | 6 | |
34 | 2019 | Primary cardiac sarcomas: A multi-national retrospective review | WEI-WU CHEN ; Loong H.H.; Srikanthan A.; Zer A.; Barua R.; Butany J.; Cusimano R.J.; Liang Y.-C.; Chang C.-H.; Iakobishvili Z.; Razak A.R.A.; Lewin J. | Cancer Medicine | 33 | 25 | |
35 | 2018 | Managing the adverse effects related to immune checkpoint inhibitors | Kuo H.-H.; WEI-WU CHEN | Journal of Nursing | 3 | 0 | |
36 | 2018 | Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer | Pezo R.C.; WEI-WU CHEN ; Berman H.K.; Mulligan A.M.; Razak A.A.; Siu L.L.; Cescon D.W.; Amir E.; Elser C.; Warr D.G.; Sridhar S.S.; Yu C.; Wang L.; Stockley T.L.; Kamel-Reid S.; Bedard P.L. | Breast Cancer Research and Treatment | 20 | 20 | |
37 | 2018 | Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancer | BANG-BIN CHEN ; YEN-SHEN LU ; CHIH-WEI YU ; CHING-HUNG LIN ; WEI-WU CHEN ; Wei S.-Y.; ANN-LII CHENG ; TIFFANY TING-FANG SHIH | European Radiology | 9 | 9 | |
38 | 2018 | Next frontiers in systemic therapy for soft tissue sarcoma | Yen C.-C.; WEI-WU CHEN | Chinese Clinical Oncology | 12 | 0 | |
39 | 2018 | A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer | WEI-WU CHEN ; Yeh D.-C.; Chao T.-Y.; CHING-HUNG LIN ; Chow L.W.-C.; DWANG-YING CHANG ; Hsieh Y.-Y.; Huang S.-M.; ANN-LII CHENG ; YEN-SHEN LU ; Taiwan Breast Cancer Consortium | Japanese Journal of Clinical Oncology | 4 | 3 | |
40 | 2017 | Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review | Prawira A.; Oosting S.F.; WEI-WU CHEN ; Delos Santos K.A.; Saluja R.; Wang L.; Siu L.L.; Chan K.K.W.; Hansen A.R. | British Journal of Cancer | 68 | 58 | |
41 | 2016 | 18F-NaF PET/CT images of cardiac metastasis from osteosarcoma | Chou Y.-H.; KUAN-YIN KO ; MEI-FANG CHENG ; WEI-WU CHEN ; RUOH-FANG YEN | Clinical Nuclear Medicine | 19 | 17 | |
42 | 2016 | Tailor the adjuvant hormonal manipulation for premenopausal breast cancer patients | WEI-WU CHEN ; CHING-HUNG LIN ; YEN-SHEN LU | Translational Cancer Research | 0 | 0 | |
43 | 2016 | Should pertuzumab be used as part of neoadjuvant treatment prior to the release of the APHINITY trial results? | WEI-WU CHEN ; CHING-HUNG LIN ; CHIUN-SHENG HUANG | Translational Cancer Research | 1 | 1 | |
44 | 2016 | A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancer | BANG-BIN CHEN ; YEN-SHEN LU ; CHING-HUNG LIN ; WEI-WU CHEN ; Wu P.-F.; CHAO-YU HSU ; CHIH-WEI YU ; Wei S.-Y.; ANN-LII CHENG ; TIFFANY TING-FANG SHIH | BMC Cancer | 20 | 17 | |
45 | 2016 | New hope for HER2-positive metastatic breast cancer treatment: Trastuzumab emtansine (T-DM1) from the perspective of nursing care | Kuo H.-H.; WEI-WU CHEN | Journal of Nursing | 2 | 0 | |
46 | 2015 | A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis | Wu P.-F.; CHING-HUNG LIN ; CHING-HUA KUO ; WEI-WU CHEN ; Yeh D.-C.; Liao H.-W.; Huang S.-M.; ANN-LII CHENG ; YEN-SHEN LU | BMC Cancer | 48 | 36 | |
47 | 2015 | High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country | CHING-HUNG LIN ; Shen C.-Y.; JIH-HSIANG LEE ; CHIUN-SHENG HUANG ; CHIH-HSIN YANG ; WEN-HUNG KUO ; DWANG-YING CHANG ; Hsiung C.-N.; KUAN-TING KUO ; WEI-WU CHEN ; I-CHUN CHEN ; Wu P.-F.; SUNG-HSIN KUO ; Chen C.-J.; YEN-SHEN LU ; ANN-LII CHENG | PLoS ONE | 10 | 6 | |
48 | 2015 | Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapy | YEN-SHEN LU ; WEI-WU CHEN ; CHING-HUNG LIN ; Yeh D.-C.; Tseng L.-M.; Wu P.-F.; Rau K.-M.; BANG-BIN CHEN ; Chao T.-C.; Huang S.-M.; CHIUN-SHENG HUANG ; TIFFANY TING-FANG SHIH ; ANN-LII CHENG ; Taiwan Breast Cancer Consortium | Clinical Cancer Research | 65 | 59 | |
49 | 2015 | TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays | CHING-HUNG LIN ; Chen I.-C.; CHIUN-SHENG HUANG ; Hu F.-C.; WEN-HUNG KUO ; KUAN-TING KUO ; Wang C.-C.; Wu P.-F.; DWANG-YING CHANG ; Wang M.-Y.; Chang C.-H.; WEI-WU CHEN ; YEN-SHEN LU ; ANN-LII CHENG | Scientific Reports | 10 | 11 | |
50 | 2014 | No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen | WEI-WU CHEN ; Chen H.-M.; CHING-HUNG LIN ; CHIUN-SHENG HUANG ; ANN-LII CHENG ; Lai M.-S.; YEN-SHEN LU | Breast Cancer Research and Treatment | 10 | 8 | |
51 | 2013 | Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy | WEI-WU CHEN ; CHIA-CHI LIN ; TA-CHEN HUANG ; ANN-LII CHENG ; KUN-HUEI YEH ; CHIH-HUNG HSU | Anticancer Research | 11 | 11 | |
52 | 2013 | The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines | WEI-WU CHEN ; DWANG-YING CHANG ; Huang S.-M.; CHING-HUNG LIN ; CHIUN HSU ; Lin M.-H.; CHIUN-SHENG HUANG ; YEN-SHEN LU ; ANN-LII CHENG | Breast | 4 | 5 | |
53 | 2013 | Personalized medicine for metastatic breast cancer | WEI-WU CHEN ; Bedard P.L. | Current Opinion in Oncology | 7 | 6 | |
54 | 2012 | The impact of diabetes mellitus on prognosis of early breast cancer in Asia | WEI-WU CHEN ; YU-YUN SHAO ; Shau W.-Y.; ZHONG-ZHE LIN ; YEN-SHEN LU ; Chen H.-M.; Kuo R.N.C.; ANN-LII CHENG ; Lai M.-S. | Oncologist | 36 | 34 |